Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIDO ERCP: Intravenous Lidocaine Infusion in ERCP Procedures
NCT07333859Phase 4Completed
- Sponsor
- Ankara City Hospital
- Start
- Feb 2026
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine, sponsored by Ankara City Hospital. Started Feb 2026; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
Beyond the preview
Go deeper on NCT07333859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07333859.